{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:08:13Z","timestamp":1790050093198,"version":"4.0.1"},"reference-count":50,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicines"],"abstract":"<jats:p>Background: Leishmaniasis is a zoonotic disease caused by protozoan parasites from Leishmania genus. Currently, there are no effective vaccines available and the available therapies are far from ideal. In particular, the development of new therapeutic strategies to reduce the infection caused by Leishmania amazonensis could be considered desirable. Different plant-derived products have demonstrated antileishmanial activity, including the essential oil (EO) from Artemisia absinthium L. (EO-Aa), Asteraceae. Methods: In the present study, the EO-Aa formulated in nanocochleates (EO-Aa-NC) was investigated in vitro against intracellular amastigotes of L. amazonensis and non-infected macrophages from BALB\/c mice. In addition, the EO-Aa-NC was also evaluated in vivo against on experimental cutaneous leishmaniasis, which body weight, lesion progression, and parasite load were determined. Results: EO-Aa-NC displayed IC50 values of 21.5 \u00b1 2.5 \u03bcg\/mL and 27.7 \u00b1 5.6 \u03bcg\/mL against intracellular amastigotes of L. amazonensis and non-infected peritoneal macrophage, respectively. In the animal model, the EO-Aa-NC (30 mg\/kg\/intralesional route\/every 4 days 4 times) showed no deaths or weight loss greater than 10%. In parallel, the EO-Aa-NC suppressed the infection in the murine model by approximately 50%, which was statistically superior (p &lt; 0.05) than controls and mice treated with EO-Aa. In comparison with Glucantime\u00ae, EO-Aa-NC inhibited the progression of infection as efficiently (p &gt; 0.05) as administration of the reference drug. Conclusions: Encochleation of EO-Aa resulted in a stable, tolerable, and efficacious antileishmanial formulation, facilitating systemic delivery of EO, with increased activity compared to administration of the free EO-Aa. This new formulation shows promising potential to future studies aimed at a new therapeutic strategy to treat leishmaniasis.<\/jats:p>","DOI":"10.3390\/medicines4020038","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T10:29:59Z","timestamp":1497004199000},"page":"38","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["In Vitro and In Vivo Evaluation of Essential Oil from Artemisia absinthium L. Formulated in Nanocochleates against Cutaneous Leishmaniasis"],"prefix":"10.3390","volume":"4","author":[{"given":"Beatriz","family":"Tamargo","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Institute of Pharmacy and Food, Havana University, Havana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianet","family":"Monzote","sequence":"additional","affiliation":[{"name":"Parasitology Department, Institute of Tropical Medicine Pedro Kouri, Havana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Pi\u00f1\u00f3n","sequence":"additional","affiliation":[{"name":"Parasitology Department, Institute of Tropical Medicine Pedro Kouri, Havana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mach\u00edn","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Pharmacy and Food, Havana University, Havana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marley","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Parasitology Department, Institute of Tropical Medicine Pedro Kouri, Havana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Scull","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Institute of Pharmacy and Food, Havana University, Havana 10400, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3639-0528","authenticated-orcid":false,"given":"William","family":"Setzer","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,6,9]]},"reference":[{"key":"ref_1","first-page":"6","article-title":"Vaccine for leishmaniasis from proteome to vaccine candidates","volume":"7","author":"Schroeder","year":"2011","journal-title":"Hum. Vaccins"},{"key":"ref_2","first-page":"24","article-title":"Animal reservoirs for visceral leishmaniasis in densely populated urban areas","volume":"2","author":"Diniz","year":"2008","journal-title":"J. Infect. Dev. Ctries"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0020-7519(00)00136-3","article-title":"The leishmaniases as emerging and reemerging zoonoses","volume":"30","author":"Ashford","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Alvar, J., V\u00e9lez, I.D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., denBoer, M., and The WHO Leishmaniasis Control Team (2012). Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035671"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-015-0021-2","article-title":"Leishmaniases diagnosis: An update on the use of immunological and molecular tools","volume":"5","author":"Tavares","year":"2015","journal-title":"Cell Biosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.det.2015.03.018","article-title":"New world and old world Leishmania infections a practical review","volume":"33","author":"Kevric","year":"2015","journal-title":"Dermatol. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/QCO.0b013e32830d0ee8","article-title":"Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis","volume":"21","author":"Schriefer","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New World cutaneous leishmaniasis: Updated review of current and future diagnosis and treatment","volume":"63","author":"Mitropoulos","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/092986709787458489","article-title":"Leishmaniasis: Current treatment and prospects for new drugs and vaccines","volume":"16","author":"Kedzierski","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1995-7645(12)60084-4","article-title":"Leishmaniasis: Current status of available drugs and new potential drug targets","volume":"5","author":"Singh","year":"2012","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2174\/1568026023393011","article-title":"Natural products as trypanocidal, antileishmanial and antimalarial drugs","volume":"2","author":"Fournet","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"Tiuman","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"ref_14","first-page":"1799","article-title":"Chemistry and leishmanicidal activity of the essential oil from Artemisia absinthium from Cuba","volume":"9","author":"Monzote","year":"2014","journal-title":"Nat. Prod. Commun."},{"key":"ref_15","first-page":"14","article-title":"Essential oils loaded in nanosystems: A developing strategy for a successful therapeutic approach","volume":"2014","author":"Bilia","year":"2014","journal-title":"eCAM"},{"key":"ref_16","first-page":"106","article-title":"Determinaci\u00f3n de saponinas y otros metabolitos secundarios en extractos acuosos de Sapindus saponaria L. (jaboncillo)","volume":"20","author":"Mena","year":"2015","journal-title":"Rev. Cuba Plantas Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0167-5699(90)90034-7","article-title":"Immunological adjuvants: A role for liposomes","volume":"11","author":"Gregoriadis","year":"1990","journal-title":"Immunol. Today"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tamargo, B., M\u00e1rquez, Y., Ram\u00edrez, W., Cedr\u00e9, B., Fresno, M., and Sierra, V.G. (2013). New proteoliposomic vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potencial as well as Th-1 adjuvant capacity. BMC Immunol., 14.","DOI":"10.1186\/1471-2172-14-S1-S12"},{"key":"ref_19","first-page":"5","article-title":"Obtenci\u00f3n de fosfol\u00edpidos a partir de la Lecitina de Soya (Glicine max L.), para usos biom\u00e9dicos","volume":"23","author":"Tamargo","year":"2011","journal-title":"Rev. Cub. Qu\u00edm."},{"key":"ref_20","first-page":"3","article-title":"Protecci\u00f3n inducida por nanococleatos derivados de proteoliposomas de Leptospira interrogans serovar Can\u00edcola","volume":"21","author":"Tamargo","year":"2012","journal-title":"VacciMonitor"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/AAC.43.5.1234","article-title":"Selective effect of 2\u2019,6\u2019-dihydroxy-4\u2019methoxychalcone isolated from Piper aduncum on Leishmania amazonensis","volume":"43","author":"Caio","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(93)90088-O","article-title":"An improved MTT assay","volume":"157","author":"Sladowski","year":"1993","journal-title":"J. Immunol. Method"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/medicines1010032","article-title":"Antileishmanial potential of tropical rainforest plant extracts","volume":"1","author":"Monzote","year":"2014","journal-title":"Medicines"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration a sensitive method for quantifying Leishmania infantum in tissues of infected mice","volume":"39","author":"Buffet","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"81188","DOI":"10.1039\/C5RA08550K","article-title":"An insight into cochleates, a potential drug delivery system","volume":"5","author":"Pawar","year":"2015","journal-title":"RSC Adv."},{"key":"ref_26","first-page":"234","article-title":"Nano and microparticles as controlled drug delivery devices","volume":"3","author":"Ravi","year":"2000","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1541-4337.12006","article-title":"Stability of essential oils: A review","volume":"12","author":"Turek","year":"2013","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jac\/dkn189","article-title":"Antileishmanial activity of nano-amphotericin B deoxycholate","volume":"62","author":"Manandhar","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1517\/17425247.2014.932347","article-title":"Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis","volume":"11","author":"Azevedo","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_30","first-page":"5529","article-title":"Nanoemulsions containing a synthetic chalcone as an alternative for treating cutaneous leshmaniasis: Optimization using a full factorial design","volume":"10","author":"Mattos","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.44.9.2356-2360.2000","article-title":"Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis","volume":"44","author":"Santangelo","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S0074-02762011000200022","article-title":"In vitro activity of amphotericin B cochleates against Leishmania chagasi","volume":"106","author":"Sesana","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1440-1711.2004.01293.x","article-title":"Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern","volume":"82","author":"Bracho","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0076-6879(05)91018-5","article-title":"Drug delivery by lipid cochleates","volume":"391","author":"Zarif","year":"2005","journal-title":"Methods Enzymol."},{"key":"ref_35","first-page":"10","article-title":"Evaluaci\u00f3n inmunotoxicol\u00f3gica, de nuevas formulaciones adyuvantes nanoparticulados sin Al(OH)3, ensayadas como candidatos vacunales contra Neisseria meningitidis","volume":"20","author":"Tamargo","year":"2011","journal-title":"VacciMonitor"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmech.2016.08.030","article-title":"Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.","volume":"124","author":"Barbosa","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijantimicag.2011.05.012","article-title":"Uptake antileishmanial activity of meglumine antomoniate-containing liposomes in Leishmania (Leishmania) major- infect macrofages","volume":"38","author":"Etel","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijpharm.2014.03.039","article-title":"Ferroportin-encapsulated nanoparticles reduce infection and improve immunity in mice infected with Leishmania major","volume":"466","author":"Rafiee","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1208\/s12249-007-9022-8","article-title":"Formulation and evaluation of microemulsion based delivery system for amphotericin B","volume":"9","author":"Darole","year":"2008","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187221108783331429","article-title":"Recent patents review on intranasal administration for CNS drug delivery","volume":"2","author":"Jogani","year":"2008","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-4632.2006.02822.x","article-title":"Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis","volume":"45","author":"Salmanpour","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1468-3083.2009.03417.x","article-title":"Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: A comparative study","volume":"24","author":"Anwar","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.parint.2011.03.004","article-title":"In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham","volume":"60","author":"Borges","year":"2011","journal-title":"Parasitol. Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.phymed.2014.03.002","article-title":"Antileishmanial activity of essential oil from Chenopodium ambrosioides and its main components against experimental cutaneous leishmaniasis in BALB\/c mice","volume":"21","author":"Monzote","year":"2014","journal-title":"Phytomedicine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1128\/AAC.40.11.2447","article-title":"In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of New World cutaneous leishmaniasis caused by Leishmania amazonensis","volume":"40","author":"Fournet","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0001-706X(95)00128-2","article-title":"Therapeutic effect of oral Kalanchoe pinnata leaf extract in murine leishmaniasis","volume":"60","author":"Costa","year":"1995","journal-title":"Acta Trop."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000237741","article-title":"Effect of oral treatment with the essential oil from Chenopodium ambrosioides against cutaneous leishmaniasis in BALB\/c mice, caused by Leishmania amazonensis","volume":"16","author":"Monzote","year":"2009","journal-title":"Res. Complement."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0169-409X(98)00014-3","article-title":"Targeting immune response induction with cochleate and liposome-based vaccines","volume":"32","author":"Kheiri","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/08982109609031122","article-title":"Mucosal and Systemic Immunization using Cochleate and Liposome Vaccine","volume":"6","author":"Mannino","year":"1996","journal-title":"J. Liposome Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4049\/jimmunol.138.3.908","article-title":"An analysis of T-cell responsiveness in Indian kala-azar","volume":"138","author":"Sacks","year":"1987","journal-title":"J. Immunol."}],"container-title":["Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6320\/4\/2\/38\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:38:36Z","timestamp":1760207916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6320\/4\/2\/38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,9]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["medicines4020038"],"URL":"https:\/\/doi.org\/10.3390\/medicines4020038","relation":{},"ISSN":["2305-6320"],"issn-type":[{"value":"2305-6320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,9]]}}}